AGEs induce caspase-mediated apoptosis of rat BMSCs via TNFα production and oxidative stress

Journal of Molecular Endocrinology

Volumn 52, Issue 1, 2013, Pages 67-76

  Weinberg, Evgeny ^a   Maymon, Tal ^a   Weinreb, Miron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Bone marrow stromal cells; Diabetes; Osteopenia

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; CD40 ANTIGEN; GLUCOSE; I KAPPA B; LYMPHOTOXIN; PIRFENIDONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MALE; NONHUMAN; OSTEOPROGENITOR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BONE MARROW STROMAL CELLS; DIABETES; OSTEOPENIA;

ANIMALS; APOPTOSIS; CASPASES; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892170029     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0229     Document Type: Article

References (73)

1. Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS & Adams DH 2001 CD40 activation-induced, Fas-dependent apoptosis and NF-kB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB Journal 15 2345-2354. (doi:10.1096/fj.01-0088com)
2. Allen DA, Harwood S, Varagunam M, Raftery MJ & Yaqoob MM 2003 High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB Journal 17 908-910. (doi:10.1096/fj.02-0130fje)
3. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A & Owen M 1980 Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clinical Orthopaedics 151 294-307.
4. Aubin JE 1999 Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. Journal of Cellular Biochemistry 72 396-410. (doi:10. 1002/(SICI)1097-4644(19990301)72:3!396::AID-JCB9O3.0.CO;2-6)
5. Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D & Faustman DL 2008 Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. PNAS 105 13644-13649. (doi:10.1073/pnas. 0803429105)
6. Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall SS & Hahn TJ 1996 Age-related changes in osteogenic stem cells in mice. Journal of Bone and Mineral Research 11 568-577. (doi:10.1002/jbmr.5650110504)
7. Chae HJ, Chae SW, Kang JS, Bang BG, Cho SB, Park RK, So HS, Kim YK, Kim HM & Kim HR 2000 Dexamethasone suppresses tumor necrosis factor-a-induced apoptosis in osteoblasts: possible role for ceramide. Endocrinology 141 2904-2913. (doi:10.1210/en.141.8.2904)
8. Chen RM, Wu GJ, Chang HC, Chen JT, Chen TF, Lin YL & Chen TL 2005 2,6-Diisopropylphenol protects osteoblasts from oxidative stressinduced apoptosis through suppression of caspase-3 activation. Annals of the New York Academy of Sciences 1042 448-459. (doi:10.1196/annals. 1338.038)
9. Chua CC, Chua BH, Chen Z, Landy C & Hamdy RC 2003 Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochimica et Biophysica Acta 1642 79-85. (doi:10.1016/S0167-4889 (03)00100-9)
10. Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB & McCarthy AD 2003 Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Molecular and Cellular Biochemistry 250 1-10. (doi:10.1023/A:1024934008982)
11. Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W & Xing L 2012 Glycogen synthase kinase-3b inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kB activation in mouse osteoblasts. Molecular Immunology 52 38-49. (doi:10.1016/j.molimm.2012.04.005)
12. Eliopoulos AG, Davies C, Knox PG, Gallagher NJ, Afford SC, Adams DH & Young LS 2000 CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Molecular and Cellular Biology 20 5503-5515. (doi:10.1128/MCB.20.15. 5503-5515.2000)
13. Etemadi N, Holien JK, Chau D, Dewson G, Murphy JM, Alexander WS, Parker MW, Silke J & Nachbur U 2013 Lymphotoxin a induces apoptosis, necroptosis and inflammatory signals with the same potency as TNF. FEBS Journal 280 5283-5297. (doi:10.1111/febs.12419)
14. Falschlehner C, Emmerich CH, Gerlach B & Walczak H 2007 TRAIL signaling: decisions between life and death. International Journal of Biochemistry & Cell Biology 39 1462-1475. (doi:10.1016/j.biocel.2007. 02.007)
15. Fatokun AA, Stone TW & Smith RA 2006 Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: the effects of glutamate and protection by purines. Bone 39 542-551. (doi:10.1016/j.bone. 2006.02.062)
16. Fernández JM, Molinuevo MS, Sedlinsky C, Schurman L, Cortizo AM & McCarthy AD 2013 Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation. European Journal of Pharmacology 706 41-47. (doi:10.1016/j.ejphar.2013.02.042)
17. Figueroa-Romero C, Sadidi M & Feldman EL 2008 Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine & Metabolic Disorders 9 301-314. (doi:10.1007/s11154-008-9104-2)
18. Forbes JM, Coughlan MT & Cooper ME 2008 Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 1446-1454. (doi:10.2337/db08-0057)
19. Franke S, Rüster C, Pester J, Hofmann G, Oelzner P & Wolf G 2011 Advanced glycation end products affect growth and function of osteoblasts. Clinical and Experimental Rheumatology 29 650-660.
20. Friedenstein AJ 1990 Osteogenic stem cells in the bone marrow. Bone and Mineral Research 7 243-272 (edited by JNM Heersche & JA Kanis: Elsevier, Amsterdam).
21. Friedenstein AJ, Piatatzky-Shapiro II & Petrakova KV 1966 Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology 16 381.
22. Funk JR, Hale JE, Carmines D, Gooch HL & Hurwitz SR 2000 Biomechanical evaluation of early fracture healing in normal and diabetic rats. Journal of Orthopaedic Research 18 126-132. (doi:10.1002/jor. 1100180118)
23. Gangoiti MV, Cortizo AM, Arnol V, Felice JI & McCarthy AD 2008 Opposing effects of bisphosphonates and advanced glycation endproducts on osteoblastic cells. European Journal of Pharmacology 600 140-147. (doi:10.1016/j.ejphar.2008.10.031)
24. Goodman WG & Hori MT 1984 Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33 825-831. (doi:10.2337/diab.33.9.825)
25. Grattendick KJ, Nakashima JM, Feng L, Giri SN & Margolin SB 2008 Effects of three anti-TNF-a drugs: etanercept, infliximab and pirfenidone on release of TNF-a in medium and TNF-a associated with the cell in vitro. International Immunopharmacology 8 679-687. (doi:10.1016/j.intimp. 2008.01.013)
26. Graves DT, Liu R, Alikhani M, Al-Mashat H & Trackman PC 2006 Diabetesenhanced inflammation and apoptosis-impact on periodontal pathology. Journal of Dental Research 85 15-21. (doi:10.1177/ 154405910608500103)
27. Hamada Y, Kitazawa S, Kitazawa R, Fujii H, Kasuga M & Fukagawa M 2007 Histomorphometric analysis of diabetic osteopenia in streptozotocininduced diabetic mice: a possible role of oxidative stress. Bone 40 1408-1414. (doi:10.1016/j.bone.2006.12.057)
28. Harada J & Sugimoto M 1998 Inhibitors of IL-1b-converting enzyme-family proteases (caspases) prevent apoptosis without affecting decreased cellular ability to reduce 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide in cerebellar granule neurons. Brain Research 793 231-243. (doi:10.1016/S0006-8993(98)00156-5)
29. Herbertson A & Aubin JE 1995 Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. Journal of Bone and Mineral Research 10 285-294. (doi:10.1002/jbmr.5650100216)
30. Ishitsuka K, Hideshima T, Neri P, Vallet S, Shiraishi N, Okawa Y, Shen Z, Raje N, Kiziltepe T, Ocio EM et al. 2008 p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications. British Journal of Haematology 141 598-606. (doi:10.1111/ j.1365-2141.2008.07044.x)
31. Katayama Y, Akatsu T, Yamamoto M, Kugai N & Nagata N 1996 Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. Journal of Bone and Mineral Research 11 931-937. (doi:10.1002/jbmr. 5650110709)
32. Keila S, Pitaru S, Grosskopf A & Weinreb M 1994 Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitro. Journal of Bone and Mineral Research 9 321-327. (doi:10.1002/jbmr.5650090306)
33. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW & Parfitt AM 1995 Bone loss and bone turnover in diabetes. Diabetes 44 775-782. (doi:10.2337/diab.44.7.775)
34. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M & Nagata K 2005 Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. Journal of Bone and Mineral Research 20 1647-1658. (doi:10.1359/JBMR.050514)
35. Li H, Qian W, Weng X, Wu Z, Li H, Zhuang Q, Feng B & Bian Y 2012 Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells. PLoS ONE 7 e37030. (doi:10.1371/journal.pone.0037030)
36. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q & Graves DT 2006 Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. Journal of Dental Research 85 510-514. (doi:10.1177/154405910608500606)
37. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(KDDC(T)) method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
38. MacEwan DJ 2000 TNF ligands and receptors-a matter of life and death. British Journal of Pharmacology 135 855-875. (doi:10.1038/sj.bjp. 0704549)
39. Maiese K, Chong ZZ & Shang YC 2007 Mechanistic insights into diabetes mellitus and oxidative stress. Current Medicinal Chemistry 14 1729-1738. (doi:10.2174/092986707781058968)
40. Malaval L, Modrowski D, Gupta AK & Aubin JE 1994 Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. Journal of Cellular Physiology 158 555-572. (doi:10.1002/jcp.1041580322)
41. Maniatopoulos C, Sodek J & Melcher AH 1988 Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell and Tissue Research 254 317-330. (doi:10.1007/BF00225804)
42. Manolagas SC & Almeida M 2007 Gone with the Wnts: b-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Molecular Endocrinology 21 2605-2614. (doi:10.1210/me.2007-0259)
43. Méndez JD, Xie J, Aguilar-Hernández M & Méndez-Valenzuela V 2010 Trends in advanced glycation end products research in diabetes mellitus and its complications. Molecular and Cellular Biochemistry 341 33-41. (doi:10.1007/s11010-010-0434-5)
44. Migliaccio S, Brama M, Fornari R, Greco EA, Spera G & Malavolta N 2007 Glucocorticoid-induced osteoporosis: an osteoblastic disease. Aging Clinical and Experimental Research 19 (3 Suppl) 5-10.
45. Mordwinkin NM, Meeks CJ, Jadhav SS, Espinoza T, Roda N, diZerega GS, Louie SG & Rodgers KE 2012 Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow. Endocrinology 153 2189-2197. (doi:10.1210/en.2011-2031)
46. Motyl KJ, McCauley LK & McCabe LR 2012 Amelioration of type I diabetesinduced osteoporosis by parathyroid hormone is associated with improved osteoblast survival. Journal of Cellular Physiology 227 1326-1334. (doi:10.1002/jcp.22844)
47. Nah SS, Choi IY, Yoo B, Kim YG, Moon HB & Lee CK 2007 Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-a in human osteoarthritic chondrocytes. FEBS Letters 581 1928-1932. (doi:10.1016/j.febslet.2007.03.090)
48. Nakazato H, Oku H, Yamane S, Tsuruta Y & Suzuki R 2002 A novel antifibrotic agent pirfenidone suppresses tumor necrosis factor-a at the translational level. European Journal of Pharmacology 446 177-185. (doi:10.1016/S0014-2999(02)01758-2)
49. Navarro JF & Mora-Fernández C 2006 The role of TNF-a in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine & Growth Factor Reviews 17 441-450. (doi:10.1016/j.cytogfr.2006.09.011)
50. Negre-Salvayre A, Salvayre R, Augé N, Pamplona R & Portero-Otín M 2009 Hyperglycemia and glycation in diabetic complications. Antioxidants & Redox Signaling 11 3071-3109. (doi:10.1089/ars.2009.2484)
51. Nishida S, Yamaguchi A, Tanizawa T, Endo E, Mashiba T, Uchiyama Y, Suda T, Yoshiki S & Takahashi HE 1994 Increased bone formation by intermittent PTH administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15 717-723. (doi:10.1016/8756-3282(94)90322-0)
52. Okazaki K, Yamaguchi T, Tanaka K, Notsu M, Ogawa N, Yano S & Sugimoto T 2012 Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcified Tissue International 91 286-296. (doi:10.1007/s00223-012-9641-2)
53. Owen M 1985 Lineage of osteogenic cells and their relationship to the stromal system. Bone and Mineral Research 3 1-25 (a yearly survey of developments in the field of bone and mineral metabolism; edited by WA Peck: Elsevier, Amsterdam).
54. Rashid G, Benchetrit S, Fishman D & Bernheim J 2004 Effect of advanced glycation end-products on gene expression and synthesis of TNF-a and endothelial nitric oxide synthase by endothelial cells. Kidney International 66 1099-1106. (doi:10.1111/j.1523-1755.2004.00860.x)
55. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS & Kazhdan I 1994 Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Developmental Biology 161 218-228. (doi:10.1006/dbio.1994.1022)
56. Roszer T 2011 Inflammation as death or life signal indiabetic fracturehealing. Inflammation Research 60 3-10. (doi:10.1007/s00011-010-0246-9)
57. Saito M, Fujii K, Mori Y & Marumo K 2006 Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporosis International 17 1514-1523. (doi:10.1007/s00198-006-0155-5)
58. Santana RB, Xu L, Chase HB, Amar S, Graves DT & Trackman PC 2003 A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52 1502-1510. (doi:10.2337/ diabetes.52.6.1502)
59. Schurman L, McCarthy AD, Sedlinsky C, Gangoiti MV, Arnol V, Bruzzone L & Cortizo AM 2008 Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Experimental and Clinical Endocrinology & Diabetes 116 333-340. (doi:10.1055/ s-2007-992786)
60. Schwartz AV 2003 Diabetes mellitus: does it affect bone? Calcified Tissue International 73 515-519. (doi:10.1007/s00223-003-0023-7)
61. Shen C, Li Q, Zhang YC, Ma G, Feng Y, Zhu Q, Dai Q, Chen Z, Yao Y, Chen L et al. 2010 Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways. Biomedicine & Pharmacotherapy 64 35-43. (doi:10.1016/j.biopha.2009.03.002)
62. Shi L, Yu X, Yang H & Wu X 2013 Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS ONE 8 e66781. (doi:10.1371/journal.pone.0066781)
63. Tabuchi C, Simmons D, Fausto A, Russell JE, Binderman I & Avioli LV 1986 Bone deficit in ovariectomized rats. Journal of Clinical Investigation 78 637-642. (doi:10.1172/JCI112621)
64. Tate CM, Blosser W, Wyss L, Evans G, Xue Q, Pan Y & Stancato L 2013 LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo. Journal of Biological Chemistry 288 6743-6753. (doi:10.1074/ jbc.M112.425553)
65. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, Carver AA, Fowlkes JL et al. 2005 Bone formation is impaired in a model of type 1 diabetes. Diabetes 54 2875-2881. (doi:10.2337/diabetes.54.10.2875)
66. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD & Garnero P 2007 Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. Journal of Biological Chemistry 282 5691-5703. (doi:10.1074/jbc.M610536200)
67. Weinreb M, Suponitzki I & Keila S 1997 Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone 20 521-526. (doi:10.1016/S8756-3282(97)00033-1)
68. Weinreb M, Kelner A & Keila S 2002 Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of PGE2 in vivo or in vitro. Journal of Endocrinology 174 127-135. (doi:10.1677/joe. 0.1740127)
69. Weinreb M, Pollak RD & Ackerman Z 2004 Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis. Journal of Hepatology 40 385-390. (doi:10.1016/j.jhep.2003.11.032)
70. Xu F, Zhang C & Graves DT 2013 Abnormal cell responses and role of TNF-a in impaired diabetic wound healing. BioMed Research International. (doi:10.1155/2013/754802)
71. Yamagishi S, Nakamura K & Inoue H 2005 Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Medical Hypotheses 65 1013-1015. (doi:10.1016/ j.mehy.2005.07.017)
72. Yun SI, Yoon HY, Jeong SY & Chung YS 2009 Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3b. Journal of Bone and Mineral Metabolism 27 140-148. (doi:10.1007/s00774-008-0019-5)
73. Zeldich E, Koren R, Dard M, Nemcovsky C & Weinreb M 2007 Enamel matrix derivative protects human gingival fibroblasts from TNFinduced apoptosis by inhibiting caspase activation. Journal of Cellular Physiology 213 750-758. (doi:10.1002/jcp.21142)